Potent inhibition of human ovarian steroidogenesis by insulin-like growth factor binding protein-4 (IGFBP-4)

J Clin Endocrinol Metab. 1998 Jan;83(1):284-7. doi: 10.1210/jcem.83.1.4630.

Abstract

Several studies have now documented the existence of IGFBPs in follicular fluid and their correlation with the health of the follicle. In particular, increased levels of IGFBP-4 have been reported in androgen-dominant atretic follicles and those from polycystic ovaries. The aim of this study was to elucidate the role of IGFBP-4 in ovarian steroidogenesis. Granulosa cells and theca tissue were incubated with or without LH or FSH in the presence or absence of IGFBP-4 (0.5-50 ng/ml). Inhibition by IGFBP-4 of estradiol production in the presence of testosterone alone was seen in three of four experiments. IGFBP-4 completely inhibited FSH-stimulated estradiol production in three experiments and caused 67% inhibition in a fourth. Similar results were obtained for theca, in which concurrent incubation with IGFBP-4 completely negated the stimulatory effects of LH on androstenedione production. The mechanism by which IGFBP-4 exerts these potent effects and the possibility that this may by IGF-independent are currently being investigated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstenedione / biosynthesis*
  • Cells, Cultured
  • Estradiol / biosynthesis*
  • Female
  • Follicle Stimulating Hormone / antagonists & inhibitors
  • Follicle Stimulating Hormone / pharmacology*
  • Granulosa Cells / drug effects
  • Granulosa Cells / metabolism*
  • Humans
  • Insulin-Like Growth Factor Binding Protein 4 / pharmacology*
  • Luteinizing Hormone / antagonists & inhibitors
  • Luteinizing Hormone / pharmacology*
  • Theca Cells / drug effects
  • Theca Cells / metabolism*

Substances

  • Insulin-Like Growth Factor Binding Protein 4
  • Androstenedione
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone